Aditus Medical
Private Company
Total funding raised: $18M
Overview
Aditus Medical is a private, commercial-stage medical device company specializing in synthetic bone graft substitutes. Its product portfolio, which appears to be approved and commercially available, targets the orthopedic and spinal surgery markets, aiming to address bone void filling needs. The company employs a direct commercialization strategy, participating in major international trade shows like MEDICA and Arab Health to build partnerships and expand its global footprint. Founded in 2016, it operates from Munich, Germany, and is positioned in the competitive but growing biomaterials segment of the medical device industry.
Technology Platform
Synthetic bone graft substitute materials formulated into multiple delivery forms (Granules, Gel, Putty, Stick) for bone void filling in orthopedic and spinal procedures.
Funding History
2Opportunities
Risk Factors
Competitive Landscape
Aditus competes in the crowded synthetic bone graft segment against major players like Medtronic, Stryker, Zimmer Biomet, and Smith & Nephew, as well as specialized biomaterial companies. Competition is based on product performance (handling, resorption rate), clinical data, price, and the strength of distributor relationships. The company's niche strategy relies on its focused product forms and direct engagement at surgical congresses to differentiate itself.